Loading…
Loading…
Baader Bank Aktiengesellschaft decreased its holdings in Boston Scientific Corporation (NYSE: BSX) by 50.5% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,770 shares of the medical equipment provider's stock after selling 12,014 shares during the
Andra AP fonden lifted its holdings in Boston Scientific Corporation (NYSE: BSX) by 144.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 169,928 shares of the medical equipment provider's stock after purchasing an additional 100,406 shares during
Bessemer Group Inc. reduced its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 98.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,473 shares of the medical equipment provider's stock after selling 3,851,493 shares during the quarter. Bessemer
Boston Scientific (BSX) reached $43.19 at the closing of the latest trading day, reflecting a -1.33% change compared to its last close.
US equities advanced during Q2, supported by another quarter of better-than-expected corporate earnings and continued enthusiasm for companies benefiting from artificial intelligence-related investment. Our bottom five contributors to return in Q2 were Accenture, CME Group, Salesforce, Boston Scientific and EOG Resources. Our top five contributors to return in Q2 were Texas Instruments, Lam Research, NXP Semiconductors, Elevance Health and Alphabet.
BSX faces Q2 results with growth expected in key businesses, but lowered full-year guidance, cost pressures and weak stock performance cloud the outlook.
Allspring Global Investments Holdings LLC reduced its holdings in shares of Boston Scientific Corporation (NYSE: BSX) by 49.7% in the first quarter, according to its most recent filing with the SEC. The fund owned 1,093,483 shares of the medical equipment provider's stock after selling 1,079,916 shares during the period. Allspring Global Investments Holdings
In the latest trading session, Boston Scientific (BSX) closed at $42.63, marking a -4.52% move from the previous day.
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for BSX and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.